The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study

<p><strong>Background</strong> The R21/Matrix-M vaccine has demonstrated high efficacy against Plasmodium falciparum clinical malaria in children in sub-Saharan Africa. Using trial data, we aimed to estimate the public health impact and cost-effectiveness of vaccine introduction ac...

Full description

Bibliographic Details
Main Authors:	Schmit, N, Topazian, HM, Natama, HM, Bellamy, D, Traoré, O, Somé, MA, Rouamba, T, Tahita, MC, Bonko, MDA, Sourabié, A, Sorgho, H, Stockdale, L, Provstgaard-Morys, S, Aboagye, J, Woods, D, Rapi, K, Datoo, MS, Ramos Lopez, F, Charles, GD, McCain, K, Ouedraogo, J-B, Hamaluba, M, Olotu, A, Dicko, A, Tinto, H, Hill, AVS, Ewer, KJ, Ghani, AC, Winskill, P
Format:	Journal article
Language:	English
Published:	Elsevier 2024

The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study

Similar Items